Understanding Epilepsy and Seizures
Epilepsy is a neurological disorder characterized by recurrent, unprovoked seizures caused by abnormal brain activity. Seizures can range from brief lapses in awareness to convulsions. Epilepsy affects millions worldwide and often requires long-term management.
There are many causes and triggers, including genetics, head injuries, infections, or developmental disorders. Common triggers include sleep deprivation, stress, and flashing lights.
Conventional Treatments
Most patients are treated with antiepileptic drugs (AEDs), such as valproate, lamotrigine, or carbamazepine. While these medications can help control seizures, some individuals experience side effects such as fatigue, weight changes, or cognitive effects. A subset of patients live with treatment-resistant epilepsy, where seizures persist despite standard therapies.
Medical Cannabis Research in Epilepsy
In recent years, researchers have studied whether cannabis-derived compounds might play a role in epilepsy management. Much of this attention has focused on cannabidiol (CBD), a non-intoxicating cannabinoid. Unlike THC, CBD does not cause a “high,” and has been the subject of FDA-approved formulations (such as Epidiolex®) for rare, severe forms of epilepsy like Dravet syndrome and Lennox-Gastaut syndrome.
How it may work (under study):
- CBD interacts with multiple receptors and channels in the nervous system.
- Research suggests it may help regulate neuronal excitability.
- Clinical trials have reported reductions in seizure frequency for some patients with severe, treatment-resistant epilepsy.
⚠️ Important: Results vary, and not all patients respond. Ongoing research continues to clarify dosage, safety, and long-term effects.
Considerations, Risks, and Safety
While some patients report improvement, medical cannabis products can also have side effects such as drowsiness, changes in appetite, or mood shifts. Products with THC may cause intoxication, anxiety, or cognitive effects, especially in younger patients.
Because of these risks, patients should:
- Always consult with a neurologist or epilepsy specialist.
- Avoid making changes to prescribed AEDs without physician supervision.
- Use only state-regulated, lab-tested products.
Alabama’s Program and Homestead Health’s Role
Under Alabama’s Compassion Act (2021), certain forms of medical cannabis may be made available for qualifying conditions, including epilepsy. Approved forms include tablets, tinctures, capsules, patches, and oils. Smokable flower and edibles are not allowed.
As a licensed processor, Homestead Health ensures:
- Consistent manufacturing under strict quality standards.
- Products tested for purity and potency by certified labs.
- Compliance with Alabama’s regulatory framework.
We do not provide medical advice or make treatment recommendations — only a licensed physician can determine if medical cannabis is appropriate for a patient with epilepsy.
Looking Ahead
Epilepsy remains an active area of medical cannabis research. Large-scale studies are underway to better understand long-term outcomes, ideal dosing, and which patient populations may benefit most.
Patients, families, and caregivers are encouraged to stay informed, consult healthcare professionals, and rely on regulated, lab-tested products if medical cannabis is part of their care plan.
